調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別

◆タイトル：Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022
◆商品コード：MAM-MD-6041
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年2月27日
◆ページ数：138
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥920,950見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、ペン型注射器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ペン型注射器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・ペン型注射器市場：タイプ別
・ペン型注射器市場：治療方法別
・ペン型注射器市場：エンドユーザー別
・ペン型注射器市場：地域別
・競争状況
・企業プロファイル
・付録

“The injection pen market is projected to grow at a CAGR of 6.0% during the forecast period”
The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.

“By type, the disposable injection pens segment is expected to grow at the highest rate during the forecast period (2017–2022).”
Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.

“By therapy, the diabetes segment is expected to grow at the highest CAGR during the study period.”
Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.

“The North American injection pen market is expected to grow at the highest CAGR during the forecast period”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
Research Coverage:
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the injection pen market. The report analyzes the market based on type, therapy, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the injection pen market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various injection pens across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the injection pen market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DESIGN 18
2.2 RESEARCH APPROACH 19
2.2.1 SECONDARY RESEARCH 20
2.2.2 PRIMARY RESEARCH 21
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 26
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
4.1 GLOBAL INJECTION PEN MARKET OVERVIEW 33
4.2 GLOBAL INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022 34
4.3 GEOGRAPHIC ANALYSIS: GLOBAL INJECTION PEN MARKET, BY THERAPY 35
4.4 GLOBAL INJECTION PEN MARKET, BY END USER, 2017 VS. 2022 36
4.5 GEOGRAPHIC SNAPSHOT: GLOBAL INJECTION PEN MARKET 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Growing Prevalence of Chronic Diseases 38
5.2.1.2 Increasing number of regulatory approvals 38
5.2.1.3 Favorable reimbursement and government support 39
5.2.2 RESTRAINTS 39
5.2.2.1 Preference for alternative drug delivery modes 39
5.2.2.2 Poor reimbursement scenario in developing countries 40
 
5.2.3 OPPORTUNITIES 40
5.2.3.1 Patent expiry of biologics to drive the demand for biosimilars 40
5.2.4 CHALLENGES 40
5.2.4.1 Needle-stick injuries & misuse of injection pen 40
6 INJECTION PEN MARKET, BY TYPE 42
6.1 INTRODUCTION 43
6.1.1 DISPOSABLE INJECTION PEN 44
6.1.2 REUSABLE INJECTION PEN 44
7 INJECTION PEN MARKET, BY THERAPY 46
7.1 INTRODUCTION 47
7.2 DIABETES 48
7.2.1 INSULIN 49
7.2.2 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) 50
7.3 GROWTH HORMONE THERAPY 51
7.4 OSTEOPOROSIS 52
7.5 FERTILITY 53
7.6 OTHER THERAPIES 54
8 INJECTION PEN MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOME CARE 57
8.3 HOSPITALS & CLINICS 58
9 INJECTION PEN MARKET, BY REGION 59
9.1 INTRODUCTION 60
9.2 NORTH AMERICA 61
9.2.1 US 63
9.2.2 CANADA 67
9.3 EUROPE 69
9.3.1 UK 72
9.3.2 GERMANY 74
9.3.3 FRANCE 76
9.3.4 REST OF EUROPE 78
9.4 ASIA PACIFIC 81
9.4.1 CHINA 84
9.4.2 JAPAN 85
9.4.3 INDIA 87
9.4.4 ROAPAC 89
9.5 ROW 91
 
10 COMPETITIVE LANDSCAPE 94
10.1 OVERVIEW 94
10.2 MARKET RANKING OF OEM COMPANIES 94
10.3 MARKET SHARE ANALYSIS 95
10.4 COMPETITIVE SCENARIO 97
10.4.1 PRODUCT LAUNCHES 98
10.4.2 REGULATORY APPROVALS 98
10.4.3 EXPANSIONS 99
10.4.4 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 99
10.4.5 ACQUISITIONS 100
11 COMPANY PROFILES 101
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 NOVO NORDISK 101
11.2 SANOFI 105
11.3 ELI LILLY AND COMPANY 108
11.4 MERCK 111
11.5 YPSOMED 113
11.6 ASTRAZENECA 116
11.7 F.HOFFMAN-LA ROCHE 118
11.8 BECTON, DICKINSON AND COMPANY (BD) 120
11.9 OWEN MUMFORD 122
11.11 NOVARTIS 123
11.12 PFIZER 125
11.13 HASELMEIER 127
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 129
12.1 DISCUSSION GUIDE 129
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 132
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 134
12.4 AVAILABLE CUSTOMIZATIONS 134
12.5 RELATED REPORTS 135
12.6 AUTHOR DETAILS 136

LIST OF TABLES

TABLE 1 INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 43
TABLE 2 DISPOSABLE INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 3 REUSABLE INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 4 INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 47
TABLE 5 INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 48
TABLE 6 INJECTION PEN MARKET FOR DIABETES THERAPY, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 7 INJECTION PEN MARKET FOR INSULIN THERAPY, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 8 INJECTION PEN MARKET FOR GLP-1 THERAPY, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 9 INJECTION PEN MARKET FOR GROWTH HORMONE THERAPY, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 10 INJECTION PEN MARKET FOR OSTEOPOROSIS THERAPY, BY REGION,
2015–2022 (USD MILLION) 52
TABLE 11 INJECTION PEN MARKET FOR FERTILITY THERAPY, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 12 INJECTION PEN MARKET FOR OTHER THERAPIES, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 13 INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 56
TABLE 14 INJECTION PEN MARKET FOR HOME CARE, BY REGION,
2015–2022 (USD MILLION) 57
TABLE 15 INJECTION PEN MARKET FOR HOSPITALS & CLINICS, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 16 INJECTION PEN MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 17 NORTH AMERICA: INJECTION PEN MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 18 NORTH AMERICA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 62
TABLE 19 NORTH AMERICA: INJECTION PEN MARKET, BY THERAPY,
2015–2022 (USD MILLION) 62
TABLE 20 NORTH AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2015–2022 (USD MILLION) 63
TABLE 21 NORTH AMERICA: INJECTION PEN MARKET, BY END USER,
2015–2022 (USD MILLION) 63
TABLE 22 FDA APPROVALS OF INJECTION PEN (2014–2017) 64
TABLE 23 US: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 66
TABLE 24 US: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 66
TABLE 25 US: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 66
TABLE 26 US: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 67
TABLE 27 CANADA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 67
TABLE 28 CANADA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 68
TABLE 29 CANADA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 68
TABLE 30 CANADA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 68
TABLE 31 APPROVALS OF INJECTION PEN (2014–2017) 70
TABLE 32 EUROPE: INJECTION PEN MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 70
TABLE 33 EUROPE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 34 EUROPE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 71
TABLE 35 EUROPE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 71
TABLE 36 EUROPE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 71
TABLE 37 UK: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 73
TABLE 38 UK: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 73
TABLE 39 UK: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 73
TABLE 40 UK: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 74
TABLE 41 GERMANY: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 75
TABLE 42 GERMANY: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 75
TABLE 43 GERMANY: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 44 GERMANY: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 76
TABLE 45 FRANCE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 76
TABLE 46 FRANCE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 77
TABLE 47 FRANCE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 77
TABLE 48 FRANCE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 77
TABLE 49 ROE: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 50 ROE: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 79
TABLE 51 ROE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 80
TABLE 52 ROE: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 80
TABLE 53 ASIA PACIFIC: INJECTION PEN MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 82
TABLE 54 ASIA PACIFIC: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 82
TABLE 55 ASIA PACIFIC: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 83
TABLE 56 ASIA PACIFIC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 83
TABLE 57 ASIA PACIFIC: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 83
TABLE 58 CHINA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 84
TABLE 59 CHINA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 84
TABLE 60 CHINA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 85
TABLE 61 CHINA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 85
TABLE 62 JAPAN: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 86
TABLE 63 JAPAN: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 86
TABLE 64 JAPAN: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 86
TABLE 65 JAPAN: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 87
TABLE 66 INDIA: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 87
TABLE 67 INDIA: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 88
TABLE 68 INDIA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 69 INDIA: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 88
TABLE 70 ROAPAC: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 89
TABLE 71 ROAPAC: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 90
TABLE 72 ROAPAC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 90
TABLE 73 ROAPAC: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 90
TABLE 74 ROW: INJECTION PEN MARKET, BY TYPE, 2015–2022 (USD MILLION) 92
TABLE 75 ROW: INJECTION PEN MARKET, BY THERAPY, 2015–2022 (USD MILLION) 92
TABLE 76 ROW: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE,
2015–2022 (USD MILLION) 93
TABLE 77 ROW: INJECTION PEN MARKET, BY END USER, 2015–2022 (USD MILLION) 93
TABLE 78 PRODUCT LAUNCHES (2014-2017) 98
TABLE 79 REGULATORY APPROVALS 98
TABLE 80 EXPANSIONS 99
TABLE 81 AGREEMENTS AND PARTNERSHIPS 99
TABLE 82 ACQUISITIONS 100


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: GLOBAL INJECTION PEN MARKET 18
FIGURE 2 GLOBAL INJECTION PEN MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 3 SAMPLING FRAME: PRIMARY INSIGHTS 22
FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 5 PRIMARY SOURCES 23
FIGURE 6 KEY INDUSTRY INSIGHTS 24
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 25
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 9 DATA TRIANGULATION METHODOLOGY 26
FIGURE 10 DISPOSABLE INJECTION PEN DOMINATED THE MARKET IN 2017 28
FIGURE 11 DIABETES SEGMENT DOMINATED THE INJECTION PEN MARKET,
BY THERAPY (2017) 29
FIGURE 12 INSULIN SEGMENT DOMINATED THE GLOBAL INJECTION PEN MARKET FOR DIABETES, BY TYPE (2017) 30
FIGURE 13 HOME CARE SEGMENT DOMINATED THE INJECTION PEN MARKET,
BY END USER (2017) 31
FIGURE 14 NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD 32
FIGURE 15 GROWING PREVALENCE OF CHRONIC DISEASES, INCREASING NUMBER OF REGULATORY APPROVALS, AND FAVORABLE REIMBURSEMENT AND GOVERNMENT SUPPORT ARE DRIVING MARKET GROWTH 33
FIGURE 16 DISPOSABLE INJECTION PEN SEGMENT DOMINATED THE MARKET IN 2017 34
FIGURE 17 DIABETES THERAPY DOMINATED THE GLOBAL INJECTION PEN MARKET IN 2017 35
FIGURE 18 HOME CARE ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017 36
FIGURE 19 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 36
FIGURE 20 INJECTION PEN MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION) 43
FIGURE 21 INJECTION PEN MARKET, BY THERAPY, 2017 VS. 2022 (USD MILLION) 47
FIGURE 22 INJECTION PEN MARKET, BY END USER, 2017 VS. 2022 (USD MILLION) 56
FIGURE 23 NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017 60
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 61
FIGURE 25 EUROPE: MARKET SNAPSHOT 69
FIGURE 26 ASIA PACIFIC: MARKET SNAPSHOT 81
FIGURE 27 ROW: MARKET SNAPSHOT 91
FIGURE 28 GLOBAL INJECTION PEN MARKET RANKING BY OEM COMPANIES (AS OF 2016) 94
FIGURE 29 INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2016 95
FIGURE 30 STRATEGIES ADOPTED BY MARKET PLAYERS (2014–2017) 97
FIGURE 31 NOVO NORDISK: COMPANY SNAPSHOT (2016) 101
FIGURE 32 SANOFI: COMPANY SNAPSHOT (2016) 105
FIGURE 33 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2016) 108
FIGURE 34 MERCK: COMPANY SNAPSHOT (2016) 111
FIGURE 35 YPSOMED: COMPANY SNAPSHOT (2016) 113
FIGURE 36 ASTRAZENECA: COMPANY SNAPSHOT (2016) 116
FIGURE 37 F.HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2016) 118
FIGURE 38 BD: COMPANY SNAPSHOT (2016) 120
FIGURE 39 NOVARTIS: COMPANY SNAPSHOT (2016) 123
FIGURE 40 PFIZER: COMPANY SNAPSHOT (2016) 125


★調査レポート[ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別] ( Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022 / MAM-MD-6041) 販売に関する免責事項
[ペン型注射器の世界市場予測（～2022年）：タイプ別(使い捨て、再使用可能)、治療別(糖尿病(インスリン、グルカゴン様ペプチド-1 )、ホルモン補充、骨粗鬆症、不妊治療)、エンドユーザー別(ホームケア、病院)、地域別] ( Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022 / MAM-MD-6041) についてEメールでお問い合わせ
◆関連調査資料◆
  • 渦巻きポンプの世界市場予測（～2022年）：タイプ別（片持インペラ、立形、両持）、段数別（一段、多段）、エンドユーザー別（水と排水、化学品、オイルとガス、電力、商業と住宅）、地域別
  • 敷地内冷却塔の世界市場予測（～2022年）：タイプ別（湿式、乾式、ハイブリッド）、デザイン別（天然、強制、誘引通風）、エンドユーザー別（発電、石油化学、石油とガス、鉄とスチール、冶金、製紙）、地域別
  • 長石市場の世界市場予測（～2022年）：タイプ別（斜長石、カリ長石）、エンドユーザー別（ガラス、セラミックス、フィラー）、地域別（ヨーロッパ、北米、南米、太平洋アジア、中東とアフリカ）
  • 関節鏡視下手術用器具の世界市場予測（～2022年）：タイプ別(インプラント、関節鏡、可視化システム、手術用シェーバー、高周波(RF)アブレーション、流体管理)、用途別(膝、腰、肩)、エンドユーザー別(病院、外来外科センター・クリニック)
  • バッテリー監視システムの世界市場予測（～2022年）：構成要素別（ハードウェア、ソフトウェア）、タイプ別（有線、無線）、電池タイプ別（リチウムイオンベース、鉛蓄電池）、エンドユーザー別（電気通信、自動車、エネルギー、産業）、地域別
  • 甲状腺機能検査の世界市場予測（～2022年）：タイプ別(TSH検査、T4検査、T3検査）、エンドユーザー別(病院、診断ラボ、研究ラボ・機関)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)
  • CROサービスの世界市場予測（～2023年）：タイプ別（創薬研究、ＣＭＣ、前臨床、臨床研究、ラボサービス）、治療領域別（腫瘍、CNS、心臓血管）、エンドユーザー別（医薬品と医療機器）
  • 可変速発電機の世界市場予測（～2022年）：タイプ別（永久磁石同期発電機・二重給電誘導発電機・自励誘導発電機・巻線形誘導発電機）、原動機別（風力タービン、ハイドロタービン、蒸気・ガスタービン、内燃機関）、技術別、パワー別、エンドユーザー別、地域別
  • 医療用電極の世界市場予測（～2022年）：使い捨て、再利用、乾式電極、湿式電極、針状電極
  • 酸素療法装置の世界市場予測（～2022年）：製品（酸素源装置（濃縮装置、シリンダー）、酸素デリバリー装置）、ポータビリティ（定置式、可搬式）、用途（慢性閉塞性肺疾患 (COPD)、喘息、嚢胞性線維症 (CF)、肺炎）、エンドユーザー別（病院、在宅医療）

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆